DAPT
作者：齐岳
发布时间：2023-09-08
09:05:35
点击数：
产品名称：DAPT
产品描述：
| 产品描述 | DAPT is a novel γ-secretase inhibitor which reduces the Aβ production (IC50: 20 nM in HEK 293 cells) and Aβ42 levels (IC50: 200 nM). |
| 靶点活性 | Aβ42:200 nM (in human primary neuronal cultures), Aβ:115 nM (in human primary neuronal cultures), Aβ:20 nM (HEK 293 cells) |
| 体外活性 | DAPT presents the dose-dependent inhibition upon both total Ab and Ab42 production in human primary neuronal cultures. Both measures of Ab production are similarly inhibited with potencies (Ab total IC50: 115 nM, Ab42 IC50: 200 nM) of 5±10-fold lower than is observed in HEK 293 cells [1]. Although the application of the maximum dose of DAPT at 75 μM had no obvious effect on cell survival, it substantially retarded CNE-2 cell proliferation in a dose-dependent manner. CNE-2 cells were treated with increasing concentrations of DAPT, and the γ-secretase-generated Notch 1 fragment Val1744-NICD was decreased after 48 h in a dose-dependent manner (P<0.01). The activation of γ-secretase was almost completely inhibited by DAPT at the concentration of 50 μM [2]. |
| 体内活性 | DAPT was administered to PDAPP mice (100 mg/kg s.c.) and the levels of DAPT and Ab were examined in the brain cortex. Peak DAPT levels of 490 ng/g were achieved in the brain 3 h after treatment and level greater than 100 ng/g (~200 nM) were sustained throughout the first 18 h. These brain concentrations of DAPT are in excess of its IC50 for lowering Ab in neuronal cultures (115 nM) and resulted in a robust and sustained pharmacodynamic effect in vivo [1]. DAPT could reduce the brain water content of ipsilateral hemispheres. In the sham-operated group, water content was 78.83 ± 0.35%. In DAPT group, brain water content was reduced compared with MCAO group (80.89 ± 0.51 vs. 83.84 ± 0.75%, P\0.05). These data indicated that DAPT protected the brain against brain ischemia damage at the early stage of cerebral ischemia [3]. |
| 细胞实验 | Human embryonic kidney cells, transfected with the gene for APP751 (HEK 293) were used for routine Ab reduction assays. The Ab peptides secreted from these cells have been characterized previously. Cells were plated in 96-well plates and allowed to adhere overnight in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum. For compound screening and dose±response testing, compounds were diluted from stock solutions in DMSO to yield a final concentration equal to 0.1% DMSO in media. Cells were pre-treated for 2 h at 378C with compounds, media were aspirated off and fresh compound solutions applied. After an additional 2-h treatment period, conditioned media were drawn off and analyzed by a sandwich ELISA (266±3D6) specific for total Ab. Reduction of Ab production was measured relative to control cells treated with 0.1% DMSO and expressed as percentage inhibition. Data from at least six doses in duplicate were fitted to a four-parameter logistical model using XLfit software in order to determine potency [1]. |
| 动物实验 | All studies were conducted with three- to four-month-old heterozygous PDAPP transgenic mice overexpressing the APPV717F a mutant form of the amyloid precursor protein. These animals have been previously shown to exhibit many of the neuropathological features of AD and to produce high levels of Ab in a regionally specific manner. Each treatment group (n=10) consisted of equal numbers of age-matched male and female animals that were fasted overnight prior to treatment. Both treatment and control groups were dosed at a volume of 10 mL/kg with compound formulated in corn oil, 5% (v/v) ethanol or vehicle alone. Tissues were processed and all Ab and APP measurements were made as described previously. After removal of the brain, the cortex from one hemisphere was homogenized, extracted with 5 M guanidine, 50 mM Tris ± pH 8.0, centrifuged, and the supernatant was used for Ab measurements. Cortex from the other hemisphere was snap frozen for analysis of compound levels. Ab levels were expressed as ng/g of wet tissue weight, and percentage reductions were calculated relative to the mean Ab level of tissue from vehicle-treated control animals. Data were analyzed with Mann± Whitney non-parametric statistics to assess significance [1]. |
| 别名 | GSI-IX, LY-374973 |
| 化合物与蛋白结合的复合物 |
Cryo-EM structure of gamma secretase in complex with a drug DAPT |
| 分子量 | 432.46 |
| 分子式 | C23H26F2N2O4 |
| CAS No. | 208255-80-5 |
存储
| Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
H2O: Insoluble
DMSO: 43.2 mg/mL (100 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
联系我们：
邮箱：2519696869@qq.com
QQ: 2519696869
电话：18066853083
微信：18066853083
公司介绍：
西安齐岳生物科技有限公司是集化学科研和定制与一体的高科技化学公司。业务范围包括化学试剂和产品的研发、生产、销售等。涉及产品为通用试剂的分销、非通用试剂的定制与研发，涵盖生物科技、化学品、中间体和化工材料等领域。
主营产品：COF、MOF单体系列：三蝶烯衍生物、金刚烷衍生物、四苯甲烷衍生物、peg、上转换、石墨烯、光电材料、点击化学、凝集素、载玻片、蛋白质交联剂、脂质体、蛋白、多肽、氨基酸、糖化学等。
